NCT03955237

Brief Summary

Background:Hyperglycemia and hypoglycemia both cause detrimental side effects for pediatric patients. Prolonged fasting time, age dependent physiological diffences and individual differences of patients make complicated the perioperative fluid therapy. Isotonic electrolyte solutions without glucose or with lower glucose concentrations recommended for intraoperative period in pediatric patients. Objective: The aim of this prospective study is to evaluate the different glucose concentrations(without dextrose, 1 % dextrose+LR, 2 % dextrose+LR) in perioperative infusion solutions according to preoperative blood glucose level to maintain normoglycemia in pediatric patients. Method: The consecutive 250 eligible pediatric patients aged between 6 months- 12 years with ASA risk score of I-II undergoing surgery lasting less than four hours were enrolled the study in six months period. Patient demographics, procedure, preoperative fasting time, preoperative and postoperative glucose levels were documented. Lactate ringer (LR) solution with % 2 glucose was infused to the patients with preoperative blood glucose level lower than 60 mg/dL, LR solution with % 1 glucose was used for the patients with preoperative blood glucose level between 60-90 mg/dL, LR solution without glucose was used for the patients with preoperative blood glucose level higher than 90 mg/dL.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 20, 2017

Completed
1.7 years until next milestone

First Posted

Study publicly available on registry

May 20, 2019

Completed
Last Updated

May 20, 2019

Status Verified

May 1, 2019

Enrollment Period

3 months

First QC Date

August 20, 2017

Last Update Submit

May 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • glucose level

    blood glucose level measurement with finger stick monitoring

    perioperative period

Secondary Outcomes (1)

  • hyperglysemia or hypoglysemia ratio

    perioperative

Study Arms (3)

non glucose infusion group

ACTIVE COMPARATOR

Drug: LR infusion LR solution without glucose; the patients with preoperative blood glucose level higher than 90 mg/dL.

Procedure: Drug: dextrose containing infusion

Drug:1% Dextrose infusion group

ACTIVE COMPARATOR

Drug:LR+ 1% Dextrose infusion LR solution with % 1 glucose: the patients with preoperative blood glucose level between 60-90 mg/dL,

Procedure: Drug: dextrose containing infusion

2% Dextrose infusion group

ACTIVE COMPARATOR

Drug:LR+ 2 % Dextrose infusion Lactate ringer (LR) solution with % 2 glucose; the patients with preoperative blood glucose level lower than 60 mg/dL,

Procedure: Drug: dextrose containing infusion

Interventions

Drug: infusing dextrose containing or non glucose fluid according to blood glucose level

Also known as: drug: non dextrose containing infusion
2% Dextrose infusion groupDrug:1% Dextrose infusion groupnon glucose infusion group

Eligibility Criteria

Age6 Months - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may not qualify if:

  • Diabetes mellitus
  • Parenteral nutrition or enteral nutrition
  • Patient with metabolic disorders,
  • ASA III-IV patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 3 different type of fluid
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc Prof

Study Record Dates

First Submitted

August 20, 2017

First Posted

May 20, 2019

Study Start

January 1, 2015

Primary Completion

April 1, 2015

Study Completion

July 1, 2016

Last Updated

May 20, 2019

Record last verified: 2019-05